Journal Article
A Phase I Study to Evaluate Two Doses of Wharton’s Jelly-Derived Mesenchymal Stromal Cells for the Treatment of De Novo High-Risk or Steroid-Refractory Acute Graft Versus Host Disease
Rupal P. Soder; Buddhadeb Dawn; Mark L. Weiss; Neil Dunavin; Scott Weir; James Mitchell; Meizhang Li; Leyla Shune; Anurag K. Singh; Siddhartha Ganguly; Marc Morrison; Haitham Abdelhakim; Andrew K. Godwin; Sunil Abhyankar; Joseph McGuirk
Stem Cell Reviews and Reports · Vol. 16, Issue 5 · pp. 979-991 · 2020